Anthem Biosciences shareholding pattern

·Pharma & Health Chart ›

Who owns itSep 2026 quarter

Promoters71.40%−0.02 pts

Foreign investors (FII)3.79%+1.21 pts

Domestic institutions (DII)12.10%−1.38 pts

of which mutual funds9.25%−1.90 pts

of which insurance companies1.72%

Public12.70%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ANTHEM₹830.15

Anthem Biosciences Ltd.

· Pharma & Health

₹ CrorePeersSYNGENE DIVISLAB GLAXO AJANTPHARM IPCALAB ABBOTINDIA MEDANTA GLENMARKMcap ₹46,631 Cr

Holding % of Total Shares 12 Months Ending	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	74.69	74.69	74.68	71.42	71.40
FII / FPI	1.67	1.36	1.28	2.58	3.79
DII	7.22	7.60	11.55	13.48	12.10
Mutual Funds	6.68	6.89	10.12	11.15	9.25

Latest: 2026-09-30 · 6 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.